5thPort Simplifies Adoption of eConsent Technology with FDA 21 CFR Part 11 Compliance
5thPort Simplifies Adoption of eConsent Technology with FDA 21 [...]
Long Live Decentralized Trials
Long Live Decentralized Trials Massive disruption from COVID-19 is [...]
5thPort Simplifies Adoption of eConsent Technology with FDA 21 CFR Part 11 Compliance
In our continued commitment to helping our clients satisfy their audit requirements, we're pleased to announce that the 5thPort eConsent and patient engagement platform has been certified as compliant with FDA 21 CFR Part 11 & EU's EUDRALEX ANNEX 11.
8 Common Misconceptions About Clinical Trials
8 Common Misconceptions About Clinical Trials Clinical trials are [...]
7 Steps to Improve Participant Retention in Clinical Trials
7 Steps to Improve Participant Retention in Clinical Trials [...]
Remote eConsent in the COVID-19 Era
Remote eConsent in the COVID-19 Era Although digital informed [...]